Dr. Eric Pierce – Massachusetts Eye & Ear Infirmary, Massachusetts General Hospital, Boston, MA
Dr. Rachel Huckfeldt – Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
Dr. Richard Lewis – Cullen Eye Institute, Baylor College of Medicine, Houston, TX
Dr. Albert Maguire – Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia, PA
Dr. Tomas Aleman – Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia, PA
Dr. Richard Weleber – Casey Eye Institute, Oregon Health & Science University, Portland, OR
Dr. Mark Pennessi – Casey Eye Institute, Oregon Health & Science University, Portland, OR
Dr. Jacque Duncan – University of California San Francisco, San Francisco, CA
Dr. Stephen Tsang – Edward S. Harkness Eye Institue, Columbia University, New York, NY
Dr. Elias Traboulsi – The Cleveland Clinic, Cleveland, OH
Dr. Allessandro Iannaccone – Duke University, Durham, NC
Dr. John Heckenlively – Kellogg Eye Center for the Study of Retinal Degenerative Diseases, University of Michigan, Ann Arbor, MI
Dr. Edwin Stone – Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
Dr. David Birch – Retina Foundation of the Southwest, Dallas, TX
Dr. Gerald Fishman – University of Illinois, Eye and Ear Infirmary, Chicago, IL, currently with Chicago Lighthouse for the Blind and Visually Impaired
Dr. Michael Gorin – University of California, Los Angeles, CA
Dr. Byron Lam – Bascom Palmer Eye Institute, University of Miami, Miami, FL
Dr. Brian Brooks – National Institutes of Health, Bethesda, MD
Dr. Paul Bernstein – Moran Eye Center, University of Utah, Salt Lake City, UT
Dr. Ian MacDonald – University of Alberta, Edmonton, AB Canada
Dr. Elise Héon – Hospital for Sick Children, Toronto, ON, Canada
Dr.Robert K. Koenekoop – Montreal Children’s Hospital, McGill University HealthCentre, Montreal, QC, Canada
Dr. Kevin Gregory-Evans – Dept of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC Canada
If you are a Retinal Specialist and would like to be added to this list, please contact the CRF Operations Manager, Cory MacDonald at email@example.com
Free Genetic Testing through Project CHM
The Choroideremia Research Foundation is happy to announce that for a limited time, FREE genetic testing is available to anyone who has received a clinical diagnosis of CHM but has not undergone genetic testing. This has been made possible through funding by the CRF and a generous donation by PTC Therapeutics (www.ptcbio.com). Anyone interested in being part of a Clinical Trial or eventually being treated for CHM must have a Genetic Test confirming their CHM diagnosis.
To have free genetic testing performed through Project CHM, you can follow the following steps:
- Download the Project CHM Genetic Testing Voucher. The completed form will be sent with your blood sample.
- Contact your doctor and have them complete the online request form at carverlab.org/request. For method of payment, they should select “Voucher”.
- Have your blood sample drawn and sent to the Carver Lab including your voucher.
- In an effort to increase insurance reimbursement for genetic testing, we are asking all Project CHM participants to submit their testing to their insurance company. You will receive an invoice from the Carver Lab marked PAID. Please file this with your insurance carrier upon receipt.
- CRF is also asking all Project CHM participants to register with the CHM Patient Registry by Clicking Here – the Patient Registry takes less than 5 min to complete.
Your doctor should receive the results of your genetic testing within 3 months and will share those results with you. If you have not received your results within 3 months, contact your doctor and ask them to follow up with the Carver Laboratory.
Please note that the voucher expires on December 31, 2019. Subject to available funds, this program may be extended so feel free to check back after this date.
Project CHM is a collaborative program between the CRF and the Carver Laboratory at the University of Iowa to provide genetic testing for those affected with CHM. The Carver Laboratory is a certified non-profit laboratory that offers low-cost genetic testing for people with retinal diseases like CHM, and the CRF is proud to partner with them to assist people affected with CHM to complete genetic testing.
If you have been diagnosed by your doctor with Choroideremia, it is important to have your diagnosis confirmed through genetic testing. A genetic test is typically performed on a blood sample and identifies the specific genetic mutation in your CHM gene. A positive genetic test with a mutation in the CHM gene provides doctors with confirmation that you have CHM and not another similar retinal disease.
Genetic testing is mandatory for those who want to be enrolled in a clinical trial or other research study on CHM. Genetic testing will also be required to receive any treatment for CHM once they have received regulatory approval.
At the end of the free genetic testing period, the cost of CHM genetic testing through the Carver Laboratory is $485 for the first family member tested. If another family member has a positive genetic test for CHM through the Carver Lab, subsequent family members will cost $115. If your family member had genetic testing done at a different laboratory, those results could also be sent to the Carver Laboratory for reduced cost. Family includes any individual from your same bloodline but does not include relatives by marriage.
For more information, you can learn more about Project CHM and genetic testing at www.curechm.org/projectCHM.
CRF Facebook Page
If you are on Facebook and wish to keep abreast of breaking news on research and fundraising, click here to go to and “Like” the official CRF Facebook page.
Team CHM raises critical funds to end blindness and find a cure for Choroideremia through athletic challenges. If you like to participate in athletic events or wish to support and follow Team CHM members as they run, jog, swim, bike & walk in support of the CRF, click here to join us on the Team CHM page!
Choroideremia Support Groups
For those living with CHM, whether it be parent, spouse or affected CHMer, there are a few avenues to get free support. These are all great resources for you to get information and input from people who are walking the same path you are. Please note: These links are provided for informational purposes. The CRF does not monitor content of these groups.
Email Support Group. To subscribe to the free email support group, send an email to: firstname.lastname@example.org
Choroideremia Facebook Group: If you are on Facebook and wish to join, click here to send a subscription request.
Choroideremia Research Foundation Wiki Page
So you would like to keep abreast of all the latest information on CHM Research? Visit the CRF Wiki Page to read articles addressing the many types of studies and research that are leading to a cure for Choroideremia! This page is being continuously updated, so be sure to bookmark it and return often. A very special and hearty “Thank You!” to CRF Member Randy Wheelock for setting up this page on our behalf!
Low Vision Products
Disclaimer: The links on this page are provided for informational purposes only. The Choroideremia Research Foundation, Inc. does not endorse any particular company, organization or group.
News and Updates
Sign up to keep updated on the latest news, events, and research.
The Choroideremia Research Foundation Inc. is an international, non-profit organization dedicated to raising funds to find a treatment or cure for Choroideremia, a rare inherited retinal degenerative disease that causes blindness.
Copyright © 2017 The Choroideremia Research Foundation Inc.